Efficacy of Shenqi Pollen Capsules for High-Altitude Deacclimatization Syndrome via Suppression of the Reoxygenation Injury and Inflammatory Response

Table 4

Analysis of the overall proportions of HADAS severity in subjects.

HADAS severity	Week 7				Week 14
	Placebo group ()	SPC group ()	RR	value	Placebo group ()	SPC group ()	RR	value
Moderate reaction (, %)	0 (0.00%)	0 (0.00%)			0 (0.00%)	0 (0.00%)
Mild reaction (, %)	62 (43.66%)	34 (23.29%)	0.17	<0.001	13 (9.15%)	1 (0.68%)	0.04	0.004
Almost no reaction (, %)	80 (56.34%)	112 (76.71%)			129 (90.85%)	145 (99.32%)

The data are presented as the number (%) of subjects. RR represents the relative risk for the SPC versus the placebo group. Symptom severities were compared using Fisher’s exact tests.